MARKET

IHE

IHE

iShares US Pharmaceuticals ETF
NYSEARCA
206.31
+2.70
+1.33%
Closed 16:00 03/01 EST
OPEN
205.36
PREV CLOSE
203.61
HIGH
206.31
LOW
204.20
VOLUME
108.58K
TURNOVER
0
52 WEEK HIGH
208.68
52 WEEK LOW
166.09
TOTAL ASSET
672.01M
YTD YIELD
17.78%
1D
5D
1M
3M
1Y
5Y
Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?
Seeking Alpha · 4d ago
PJP: Pharma Investing Is Difficult And This Fund Doesn't Make It Easier
Invesco Dynamic Pharmaceuticals ETF is a passively managed fund that tracks the Dynamic Pharmaceutical Intellidex Index. Investing in the pharmaceutical industry is challenging due to the need for specialized knowledge and the industry's underperformance. PJP is overvalued, has lower expected earnings growth, and higher fees compared to its competitors.
Seeking Alpha · 4d ago
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
Positive results from trials by Zealand Pharma pushed shares of the company 30% higher on Monday. Zealand Pharma's drug showed positive results in 83% of patients in liver disease trials. Dozens of companies are developing weight-loss drugs to fight obesity and associated diseases. Novo Nordisk and Eli Lilly are the main players in the growing market.
Benzinga · 5d ago
Weekly Report: what happened at IHE last week (0219-0223)?
Weekly Report · 5d ago
Looking for Bargain Hunting? Top-Ranked ETFs to Buy
NASDAQ · 02/23 18:00
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
NASDAQ · 02/20 11:20
Weekly Report: what happened at IHE last week (0212-0216)?
Weekly Report · 02/19 12:39
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
NASDAQ · 02/15 11:20
More
Profile
Fund Name
iShares US Pharmaceuticals ETF
Inception Date
2006-05-01
Benchmark
DJ US Select Pharms TR USD
Advisor Company
BlackRock Fund Advisors
Custodian
Citibank NA
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead